Groowe Groowe / Newsroom / LLY
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

LLY News

Eli Lilly & Co.

DigiCert Introduces Quantum Central to Help Organizations Prepare for Post-Quantum Cryptography

globenewswire.com
MSFT GOOG AMZN IBM ORCL CSCO NVDA INTC AMD QCOM AMAT MU ADBE CRM ACN T VZ CMCSA NFLX DIS BA GD LMT RTX HON GE CAT JPM BAC WFC C GS MS AXP V MA PYPL KO PEP MCD SBUX COST WMT HD UNH JNJ PFE MRK ABBV BMY LLY GILD AMGN BIIB REGN VRTX GNTX CTAS PAYX ADP LRCX KLAC NXPI MRVL SNPS CDNS MCHP ON ADI TXN QGEN ILMN MDT SYK ISRG ALGN EW TMO DHR GOOGL AAPL META TSLA

100 Black Men of America Celebrated 40 Years of National Impact at Landmark Conference in New York City

prnewswire.com
KO WFC UPS LLY PFE MSCI WMT

Long-Acting Drugs Market to Reach US$ 13.3 Billion by 2033 Expands Amid Advances in Sustained Drug Delivery and Chronic Disease Management - Persistence Market Research

prnewswire.com
LLY JNJ NVS AZN

Flare Therapeutics Secures $85M in Insider-Led Series C Financing and Appoints Anna Protopapas as Chief Executive Officer

globenewswire.com
MRNA NUVL PFE LLY NVS

Kinaset Therapeutics Appoints Daniel G. Welch as Board Chair and David Lubner as Independent Director and Audit Committee Chair

businesswire.com
ULTA CRSP GILD PFE NVS REGN UCB LLY BIIB ARCL

Innovent Biologics and Lilly Enter into Commercialization Agreement for VerzeniosĀ® (abemaciclib) in Mainland China

prnewswire.com
LLY

Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with chronic lymphocytic leukemia (CLL) across all lines of therapy

prnewswire.com
LLY

Lilly launches "The Memory Radio Station" across Europe, inviting the public to visually reconstruct fading memories through GenAI

prnewswire.com
LLY

IgA Nephropathy Clinical Trial Space Intensifies with 25+ Companies in Active Development | DelveInsight

globenewswire.com
NVS VRTX BIIB VTRS AZN IONS TAK ARWR BHVN NVO LLY LXRX XRTX REGN FMS MDT AMPH DRCT BMRC MAZE

$960 Billion Proteins & Protein Crystals Market Outlook, 2030 | High Investment and Funding in Structural Biology, Biopharmaceuticals, and Advanced Drug Development

globenewswire.com
DHR TMO IFF AMGN LLY PFE